Top Markets
Coin of the day
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Classifica tra le azioni #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Prezzo delle azioni
$24.37
Capitalizzazione di mercato
$1.30B
Variazione (1 giorno)
-7.16%
Variazione (1 anno)
-
Paese
US
Scambia Seaport Therapeutics, Inc. Common Stock (SPTX)

Categoria

Storico del prezzo dell'azione per Seaport Therapeutics, Inc. Common Stock (SPTX)
Prezzo di chiusura più alto: $24.31 il 2026-08-01

Prezzo di chiusura più basso: $16.84 il 2026-05-01
Storico del prezzo dell'azione di Seaport Therapeutics, Inc. Common Stock dal 2026 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
Non abbastanza dati per le date fornite.
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH